Vaxcyte, Inc. (PCVX)
65.65
+4.84
(+7.96%)
USD |
NASDAQ |
Nov 04, 16:00
65.00
-0.65
(-0.99%)
After-Hours: 19:30
Vaxcyte Total Return Price : 65.65 for Nov. 4, 2026
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| November 03, 2026 | 60.81 |
| November 02, 2026 | 60.62 |
| October 30, 2026 | 62.03 |
| October 29, 2026 | 62.61 |
| October 28, 2026 | 61.46 |
| October 27, 2026 | 60.67 |
| October 26, 2026 | 59.97 |
| October 23, 2026 | 60.43 |
| October 22, 2026 | 62.85 |
| October 21, 2026 | 63.23 |
| October 20, 2026 | 66.23 |
| October 19, 2026 | 63.68 |
| October 16, 2026 | 63.62 |
| October 15, 2026 | 65.27 |
| October 14, 2026 | 67.55 |
| October 13, 2026 | 66.80 |
| October 12, 2026 | 70.65 |
| October 09, 2026 | 71.38 |
| October 08, 2026 | 65.02 |
| October 07, 2026 | 66.96 |
| October 06, 2026 | 66.70 |
| October 05, 2026 | 73.82 |
| October 02, 2026 | 56.48 |
| October 01, 2026 | 56.05 |
| September 30, 2026 | 56.90 |
| Date | Value |
|---|---|
| September 29, 2026 | 56.69 |
| September 28, 2026 | 58.27 |
| September 25, 2026 | 56.21 |
| September 24, 2026 | 56.90 |
| September 23, 2026 | 56.50 |
| September 22, 2026 | 59.02 |
| September 21, 2026 | 58.92 |
| September 18, 2026 | 58.13 |
| September 17, 2026 | 60.37 |
| September 16, 2026 | 58.77 |
| September 15, 2026 | 59.21 |
| September 14, 2026 | 59.54 |
| September 11, 2026 | 59.47 |
| September 10, 2026 | 58.90 |
| September 09, 2026 | 59.51 |
| September 08, 2026 | 60.36 |
| September 04, 2026 | 61.16 |
| September 03, 2026 | 61.17 |
| September 02, 2026 | 61.58 |
| September 01, 2026 | 60.81 |
| August 31, 2026 | 60.74 |
| August 28, 2026 | 59.84 |
| August 27, 2026 | 61.16 |
| August 26, 2026 | 61.09 |
| August 25, 2026 | 61.09 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| Moderna, Inc. | 258.28 |
| Vir Biotechnology, Inc. | 11.78 |
| Anavex Life Sciences Corp. | 1.255 |
| Revolution Medicines, Inc. | 199.68 |
| Foghorn Therapeutics, Inc. | 2.125 |